Testing Safety, Efficacy of Pharmacotherapy in Hospitalized Heart Failure Patients

In patients hospitalized for acute decompensated heart failure with reduced ejection fraction, administering sacubitril-valsartan led to more improvement in levels of cardiac biomarkers compared to enalapril, with no adverse safety signals.